Integra Lifesciences Holdings (IART) Return on Capital Employed (2010 - 2026)
Integra Lifesciences Holdings recorded quarterly Return on Capital Employed of 14.38% in Q1 2026, up 7.65% quarter-over-quarter from 15.57% in Q4 2025, and down 1467.0% year-over-year from 1.05% in Q1 2025.
Integra Lifesciences Holdings' Return on Capital Employed history runs 17 years deep, the most recent figure standing at 14.38% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 1467.0% year-over-year to 14.38%; the TTM figure through Mar 2026 stood at 14.38% (down 1467.0% YoY), while the FY2025 annual figure was 14.67%, down 1562.0% from the prior year.
- Return on Capital Employed came in at 14.38% for Q1 2026 at Integra Lifesciences Holdings, up from 15.57% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 6.77% in Q4 2022 to a low of 17.09% in Q2 2025.
- A 5-year average of 0.61% and a median of 2.18% in 2024 frame the typical range for Return on Capital Employed.
- Across the five-year window, Return on Capital Employed surged 149 bps in 2022 and plunged 1878 bps in 2025, its largest moves.
- Integra Lifesciences Holdings' Return on Capital Employed stood at 6.77% in 2022, then sank by 52 bps to 3.23% in 2023, then sank by 72 bps to 0.91% in 2024, then plunged by 1815 bps to 15.57% in 2025, then climbed by 8 bps to 14.38% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 14.38%, 15.57%, and 14.6% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 7.62% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 11.57% |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn | -14.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.38% |
| Dec 31, 2025 | -15.57% |
| Sep 30, 2025 | -14.60% |
| Jun 30, 2025 | -17.09% |
| Mar 31, 2025 | 0.29% |
| Dec 31, 2024 | 0.91% |
| Sep 30, 2024 | 0.91% |
| Jun 30, 2024 | 1.70% |
| Mar 31, 2024 | 2.18% |
| Dec 31, 2023 | 3.23% |
| Sep 30, 2023 | 4.21% |
| Jun 30, 2023 | 5.37% |
| Mar 31, 2023 | 6.48% |
| Dec 31, 2022 | 6.77% |
| Sep 30, 2022 | 6.60% |
| Jun 30, 2022 | 6.46% |
| Mar 31, 2022 | 6.23% |
| Dec 31, 2021 | 5.74% |
| Sep 30, 2021 | 5.62% |
| Jun 30, 2021 | 5.66% |
| Mar 31, 2021 | 4.75% |
| Dec 31, 2020 | 4.83% |
| Sep 30, 2020 | 4.26% |
| Jun 30, 2020 | 1.77% |
| Mar 31, 2020 | 2.83% |
| Dec 31, 2019 | 3.13% |
| Sep 30, 2019 | 3.04% |
| Jun 30, 2019 | 4.64% |
| Mar 31, 2019 | 4.10% |
| Dec 31, 2018 | 3.85% |
| Sep 30, 2018 | 2.88% |
| Jun 30, 2018 | 2.38% |
| Mar 31, 2018 | 2.09% |
| Dec 31, 2017 | 1.82% |
| Sep 30, 2017 | 3.82% |
| Jun 30, 2017 | 5.16% |
| Mar 31, 2017 | 5.93% |
| Dec 31, 2016 | 6.81% |
| Sep 30, 2016 | 5.94% |
| Jun 30, 2016 | 4.69% |
| Mar 31, 2016 | 4.89% |
| Dec 31, 2015 | 4.79% |
| Sep 30, 2015 | 5.35% |
| Jun 30, 2015 | 6.41% |
| Mar 31, 2015 | 5.57% |
| Dec 31, 2014 | 4.71% |
| Sep 30, 2014 | 7.12% |
| Jun 30, 2014 | 3.71% |
| Mar 31, 2014 | 3.68% |
| Dec 31, 2013 | 3.31% |
| Sep 30, 2013 | -0.87% |
| Jun 30, 2013 | 3.92% |
| Mar 31, 2013 | 5.13% |
| Dec 31, 2012 | 6.91% |
| Sep 30, 2012 | 5.93% |
| Jun 30, 2012 | 5.87% |
| Mar 31, 2012 | 4.92% |
| Dec 31, 2011 | 5.19% |
| Sep 30, 2011 | 6.73% |
| Jun 30, 2011 | 8.35% |
| Mar 31, 2011 | 11.41% |
| Dec 31, 2010 | 12.53% |
| Sep 30, 2010 | 12.08% |